{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:53:02Z","timestamp":1789977182134,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T00:00:00Z","timestamp":1396051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11882-014-0441-9","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T10:12:52Z","timestamp":1396001572000},"source":"Crossref","is-referenced-by-count":34,"title":["Aspirin Desensitization: Useful Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Aspirin-Exacerbated Respiratory Disease (AERD)?"],"prefix":"10.1007","volume":"14","author":[{"given":"Ludger","family":"Klimek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Dollner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pfaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"issue":"5","key":"441_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/02770908709070955","volume":"24","author":"F Widal","year":"1987","unstructured":"Widal F, Abrami P, Lermoyez J. First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)\u2009\u2212\u20091922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez. J Asthma. 1987;24(5):297\u2013300.","journal-title":"J Asthma"},{"issue":"1","key":"441_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0091-6749(99)70106-5","volume":"104","author":"A Szczeklik","year":"1999","unstructured":"Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104(1):5\u201313.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 12","key":"441_CR3","first-page":"5","volume":"57","author":"O Pfaar","year":"2006","unstructured":"Pfaar O, Klimek L. Eicosanoids, aspirin-intolerance and the upper airways\u2013current standards and recent improvements of the desensitization therapy. J Physiol Pharmacol. 2006;57 Suppl 12:5\u201313.","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"441_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2500\/108854190778879918","volume":"11","author":"Hirschberg","year":"1990","unstructured":"Hirschberg. Anaphylactoid reaction to aspirin, (1902). Allergy Proc. 1990;11(5):249\u201350. discussion 251-2.","journal-title":"Allergy Proc"},{"issue":"5","key":"441_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2500\/108854193778774065","volume":"14","author":"F Widal","year":"1993","unstructured":"Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. 1992 [Anaphylaxis and idiosyncrasy. 1992]. Allergy Proc Off J Reg State Allergy Soc. 1993;14(5):373\u20136. discussion 371-2.","journal-title":"Allergy Proc Off J Reg State Allergy Soc"},{"issue":"5","key":"441_CR6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","volume":"68","author":"M Samter","year":"1968","unstructured":"Samter M, Beers Jr RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975\u201383.","journal-title":"Ann Intern Med"},{"issue":"5","key":"441_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","volume":"111","author":"A Szczeklik","year":"2003","unstructured":"Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111(5):913\u201321. quiz 922.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"441_CR8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.118.5.1470","volume":"118","author":"KS Babu","year":"2000","unstructured":"Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118(5):1470\u20136.","journal-title":"Chest"},{"issue":"3","key":"441_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.all.0000225153.45027.6a","volume":"6","author":"O Pfaar","year":"2006","unstructured":"Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol. 2006;6(3):161\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"441_CR10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0032-1325618","volume":"33","author":"AA White","year":"2012","unstructured":"White AA, Stevenson DD. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med. 2012;33(6):588\u201394.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"441_CR11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/resp.12076","volume":"18","author":"J Roca-Ferrer","year":"2013","unstructured":"Roca-Ferrer J et al. Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics. Respirology. 2013;18(4):711\u20137.","journal-title":"Respirology"},{"key":"441_CR12","doi-asserted-by":"crossref","unstructured":"Klimek L, Pfaar O, Kirsche H. Die adaptive Desaktivierungsbehandlung bei Patienten mit ASS-Intoleranz-Syndrom: \u00dcbersicht \u00fcber ein urs\u00e4chlich-orientiertes Therapieprinzip. Allergologie 2014; 25-32.","DOI":"10.5414\/ALX01626"},{"issue":"11","key":"441_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1398-9995.2001.00913.x","volume":"56","author":"H Mita","year":"2001","unstructured":"Mita H et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy. 2001;56(11):1061\u20137.","journal-title":"Allergy"},{"issue":"7\u20138","key":"441_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.clinbiochem.2012.12.005","volume":"46","author":"A Narayanankutty","year":"2013","unstructured":"Narayanankutty A et al. Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD). Clin Biochem. 2013;46(7\u20138):566\u201378.","journal-title":"Clin Biochem"},{"issue":"7","key":"441_CR15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","volume":"66","author":"ML Kowalski","year":"2011","unstructured":"Kowalski ML et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI\/ENDA(#) and GA2LEN\/HANNA. Allergy. 2011;66(7):818\u201329. The \u201cofficial\u201d statement of EAACI and ENDA.","journal-title":"Allergy"},{"issue":"1\u20133","key":"441_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","volume":"533","author":"A Szczeklik","year":"2006","unstructured":"Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol. 2006;533(1\u20133):145\u201355.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"441_CR17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","volume":"101","author":"AS Cowburn","year":"1998","unstructured":"Cowburn AS et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101(4):834\u201346.","journal-title":"J Clin Invest"},{"issue":"19","key":"441_CR18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","volume":"347","author":"AR Sousa","year":"2002","unstructured":"Sousa AR et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493\u20139.","journal-title":"N Engl J Med"},{"key":"441_CR19","doi-asserted-by":"crossref","unstructured":"Dollner Rea. In vitro Diagnostik des ASS-Intoleranz-Syndroms (Aspirin-exacerbated Respiratory Disease: AERD). Allergologie 2014; 10-18. Excellent overview of different approaches of in-vitro diagnostic tests for AERD.","DOI":"10.5414\/ALX01584"},{"issue":"5","key":"441_CR20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1067\/mai.2002.123534","volume":"109","author":"J Mullol","year":"2002","unstructured":"Mullol J et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 2002;109(5):824\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"441_CR21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.00017408","volume":"33","author":"L Pujols","year":"2009","unstructured":"Pujols L et al. Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. Eur Respir J. 2009;33(3):502\u20138.","journal-title":"Eur Respir J"},{"issue":"1","key":"441_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","volume":"160","author":"C Picado","year":"1999","unstructured":"Picado C et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1999;160(1):291\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"441_CR23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2004.07.050","volume":"114","author":"L Pujols","year":"2004","unstructured":"Pujols L et al. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol. 2004;114(4):814\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"441_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","volume":"128","author":"J Roca-Ferrer","year":"2011","unstructured":"Roca-Ferrer J et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol. 2011;128(1):66\u201372. e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"441_CR25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11882-008-0037-3","volume":"8","author":"JM Guilemany","year":"2008","unstructured":"Guilemany JM, Roca-Ferrer J, Mullol J. Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis. Curr Allergy Asthma Rep. 2008;8(3):219\u201326.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"441_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.iac.2012.11.002","volume":"33","author":"J Mullol","year":"2013","unstructured":"Mullol J, Picado C. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin N Am. 2013;33(2):163\u201376. Excellent update on the current knowledge of links between nasal polyps and AERD.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"42","key":"441_CR27","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","volume":"110","author":"T Liu","year":"2013","unstructured":"Liu T et al. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013;110(42):16987\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"441_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.iac.2012.11.003","volume":"33","author":"T Burnett","year":"2013","unstructured":"Burnett T, Katial R, Alam R. Mechanisms of aspirin desensitization. Immunol Allergy Clin N Am. 2013;33(2):223\u201336.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"4","key":"441_CR29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","volume":"132","author":"JW Steinke","year":"2013","unstructured":"Steinke JW et al. Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2013;132(4):856\u201365. e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"441_CR30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000;16(3):432\u20136.","journal-title":"Eur Respir J"},{"issue":"1","key":"441_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00063198-200401000-00009","volume":"10","author":"A Szczeklik","year":"2004","unstructured":"Szczeklik A et al. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med. 2004;10(1):51\u20136.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"441_CR32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","volume":"89","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Annals Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2002;89(5):474\u20138.","journal-title":"Annals Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"5","key":"441_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0091-6749(76)90059-2","volume":"57","author":"CR Zeiss","year":"1976","unstructured":"Zeiss CR, Lockey RF. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol. 1976;57(5):440\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"441_CR34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","volume":"98","author":"DD Stevenson","year":"1996","unstructured":"Stevenson DD et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98(4):751\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"441_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","volume":"85","author":"JM Sweet","year":"1990","unstructured":"Sweet JM et al. Long-term effects of aspirin desensitization\u2013treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85(1 Pt 1):59\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"441_CR36","first-page":"17","volume":"36","author":"M Schmitz-Schumann","year":"1982","unstructured":"Schmitz-Schumann M, Schaub E, Virchow C. Inhalation provocation test with lysine-acetylsalicylic acid in patients with analgetics-induced asthma (author\u2019s transl). Prax Klin Pneumol. 1982;36(1):17\u201321.","journal-title":"Prax Klin Pneumol"},{"issue":"1","key":"441_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","volume":"66","author":"DD Stevenson","year":"1980","unstructured":"Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol. 1980;66(1):82\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"441_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4193\/Rhino09.113","volume":"49","author":"B Forer","year":"2011","unstructured":"Forer B et al. Aspirin desensitization for ASA triad patients\u2013prospective study of the rhinologist`s perspective. Rhinology. 2011;49(1):95\u20139.","journal-title":"Rhinology"},{"issue":"1","key":"441_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","volume":"111","author":"MP Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"441_CR40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2009.07.008","volume":"29","author":"L Klimek","year":"2009","unstructured":"Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin N Am. 2009;29(4):669\u201375.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"6","key":"441_CR41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10753-013-9699-7","volume":"36","author":"A Aktas","year":"2013","unstructured":"Aktas A, Kurt E, Gulbas Z. Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease. Inflammation. 2013;36(6):1553\u20139.","journal-title":"Inflammation"},{"issue":"4","key":"441_CR42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","volume":"73","author":"DD Stevenson","year":"1984","unstructured":"Stevenson DD et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol. 1984;73(4):500\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"8755","key":"441_CR43","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)93185-C","volume":"337","author":"G Patriarca","year":"1991","unstructured":"Patriarca G et al. Prevention of relapse in nasal polyposis. Lancet. 1991;337(8755):1488.","journal-title":"Lancet"},{"issue":"8","key":"441_CR44","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.MLG.0000166702.38850.1B","volume":"115","author":"AA Parikh","year":"2005","unstructured":"Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope. 2005;115(8):1385\u201390.","journal-title":"Laryngoscope"},{"issue":"9","key":"441_CR45","doi-asserted-by":"crossref","first-page":"1196-8","DOI":"10.1007\/s00108-010-2661-y","volume":"51","author":"C Umbreit","year":"2010","unstructured":"Umbreit C et al. Aspirin-Intolerance-Syndrome: a common and interdisciplinary disease. Internist (Berlin). 2010;51(9):1196-8\u2013200-1.","journal-title":"Internist (Berlin)"},{"issue":"24","key":"441_CR46","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1001\/jama.292.24.3017","volume":"292","author":"RR Gollapudi","year":"2004","unstructured":"Gollapudi RR et al. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292(24):3017\u201323.","journal-title":"JAMA"},{"issue":"4","key":"441_CR47","first-page":"252","volume":"22","author":"G M\u00fchlmeier","year":"2013","unstructured":"M\u00fchlmeier G, Maier H. Bestimmung organbezogener Schwellenwerte bei ASS\/Salicylat-Intoleranz durch intraven\u00f6se Provokation. Allergol J. 2013;22(4):252\u20138.","journal-title":"Allergol J"},{"issue":"8","key":"441_CR48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5414\/ALP29322","volume":"29","author":"O Pfaar","year":"2006","unstructured":"Pfaar O, Spielhaupter M, Wrede H. Aspirin desensitization on patients with aspirin intolerance and nasal polyps - a new therapeutic approach by the intravenous route. Allergologie. 2006;29(8):322\u201331.","journal-title":"Allergologie"},{"issue":"1","key":"441_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","volume":"119","author":"JY Lee","year":"2007","unstructured":"Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119(1):157\u201364.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"441_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00106-011-2444-3","volume":"60","author":"R Weber","year":"2012","unstructured":"Weber R et al. Aspirin desensitization: therapy options in patients with aspirin-exacerbated respiratory disease. HNO. 2012;60(4):369\u201383.","journal-title":"HNO"},{"issue":"3","key":"441_CR51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOO.0b013e3283450102","volume":"19","author":"H Rizk","year":"2011","unstructured":"Rizk H. Role of aspirin desensitization in the management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2011;19(3):210\u20137.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"441_CR52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejvs.2009.01.009","volume":"37","author":"E Tournoij","year":"2009","unstructured":"Tournoij E et al. The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis. Eur J Vasc Endovasc Surg. 2009;37(5):597\u2013603.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"10","key":"441_CR53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-2002-35002","volume":"81","author":"J Gosepath","year":"2002","unstructured":"Gosepath J, Schafer D, Mann WJ. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day. Laryngorhinootologie. 2002;81(10):732\u20138.","journal-title":"Laryngorhinootologie"},{"issue":"9","key":"441_CR54","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","volume":"63","author":"A Rozsasi","year":"2008","unstructured":"Rozsasi A et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300\u00a0mg aspirin daily. Allergy. 2008;63(9):1228\u201334.","journal-title":"Allergy"},{"key":"441_CR55","first-page":"3","volume":"23","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:3. preceding table of contents, 1-298.","journal-title":"Rhinol Suppl"},{"issue":"1","key":"441_CR56","first-page":"79","volume":"58","author":"S Albu","year":"2004","unstructured":"Albu S et al. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg. 2004;58(1):79\u201386.","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"441_CR57","first-page":"59","volume":"8","author":"S Jantti-Alanko","year":"1989","unstructured":"Jantti-Alanko S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinol Suppl. 1989;8:59\u201364.","journal-title":"Rhinol Suppl"},{"issue":"1","key":"441_CR58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lary.24220","volume":"124","author":"DW Jang","year":"2014","unstructured":"Jang DW et al. Aspirin sensitivity does not compromise quality-of-life outcomes in patients with Samter's triad. Laryngoscope. 2014;124(1):34\u20137.","journal-title":"Laryngoscope"},{"issue":"2","key":"441_CR59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00405-012-2048-x","volume":"270","author":"M Havel","year":"2013","unstructured":"Havel M et al. Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol. 2013;270(2):571\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"441_CR60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/all.12131","volume":"68","author":"K Fruth","year":"2013","unstructured":"Fruth K et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy. 2013;68(5):659\u201365.","journal-title":"Allergy"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-014-0441-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0441-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:13:47Z","timestamp":1648703627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-014-0441-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,29]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s11882-014-0441-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,29]]},"article-number":"441"}}